Back to Jacobs Levy Equity Management, Inc. Jacobs Levy Equity Management, Inc.

AXSMAXSM

Showing 1 of 7 quarters

Position history for Jacobs Levy Equity Management, Inc.Jacobs Levy Equity Management, Inc.'s holdings in Axsome Therapeutics, Inc.

Yes. Jacobs Levy Equity Management holds 11,533 shares of AXSM (Axsome Therapeutics), worth $2.8M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$2.8M

Current Shares

11,533

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
11,533
—
$2.8M0.0%$244.77
36

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used